YS Shin, Takeda K., Ohnishi H., Jia Y., Shiraishi Y., Fine J., Lundel D., Jenh C., Manfra D., Erwin W. Gelfand. Targeting CXCR3 Reduces Ligand-Induced T Cell Activation but not Development of Lung Allergic Responses, Ann Allergy Asthma Immunol. (Accepted)
YS Shin, Park JW, Lee YW, Kim CW, Dhong HJ, Park HS, Cho YJ, Cho SH, Pyun BY, Lee KH, Lee HR, Hong CS. Current status of oriental medicine in treating Korean allergy patients. Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):99-104.
YS Shin, Takeda K, Gelfand EW. Understanding asthma using animal models, Allergy Asthma Immunol Res. Oct;1(1):10-8.
YS Shin , Lee YW, Choi YH, Park B, Jee YK, Choi SK, Kim EG, Park JW, Hong CS. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers, Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):910-5.
YS Shin, Choi GS, Park HJ, Ye YM, Park HS. A case of vasospasm and urticaria by shiso ingestion. Ann Allergy Asthma Immunol. 2009 Feb;102(2):169.
YS Shin, JH Choi, DH Nahm, HS Park, JH Cho, CH Suh. Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis, Yonsei Med J. 2005 Aug 31; 46(4):464-70.
